'A Variant Worse Than Delta': Fauci Dials Fear To 11 As Emerging 'Lambda' Strain Appears More Resistant To Vaccine Dr. Anthony Fauci, the country's top infectious...
Biotech penny stocks are heating up right now; here's 3 to watch The post Best Biotech Penny Stocks For Your Small-Caps Watchlist Right Now appeared first...
In this webinar from GEN, The CRISPR Journal, and sponsored by TriLink, Professor Dan Peer will discuss the state of RNA-based therapeutics, particularly developing a self-assembled...
The UK government has confirmed that the national COVID-19 vaccination campaign will be extended to include 16 and The post UK extends COVID vaccination to 16...
The Delta variant is surging as case numbers hit new highs in many countries around the world, including the US. One of the dynamics that has...
The two companies are collaborating in the development of mRNA vaccines for SARS-CoV-2 and seasonal influenza, but the deal signals Sanofi's desire to advance the mRNA...
- by New Deal democratIt seems pretty clear that Delta burns through the dry tinder very fast - on the order of 9 to 12 weeks...
Translate Bio is partnering with Sanofi in developing MRT5500, an mRNA vaccine based on Translate’s proprietary MRT™ platform, which it acquired from Shire in 2017.
Finally, Australia’s vaccine rollout is beginning to gain traction. In July, around 4.5 million vaccinations were administered – more than double the rate achieved in May....
Investors could be shifting their focus to biotech stocks, should you do the same? The post 4 Biotech Stocks For Your August 2021 Watchlist appeared first...
Mandating vaccines risks turning a highly effective public health intervention into a contentious battleground — but it also may save lives.
The COVID-19 pandemic has jumpstarted innovations in viral detection technologies from electrical-based assays to saliva sampling. The post Methods to Detect Viruses Get a Boost, Thanks...
How a team quickly fielded SARS-CoV-2 countermeasures until vaccines were developed. The post Dousing the Pandemic’s Flames appeared first on GEN - Genetic Engineering and Biotechnology...
As one of the founding execs and longtime chief medical officer at Betta Pharma, Fenlai Tan isn’t just well aware of the allure of a me-better...
Should investors be focusing on health care stocks as coronavirus fears escalate? The post Top Health Care Stocks To Buy Now? 4 For Your Watchlist appeared...
Nanobodies have been developed that can bind and neutralize the SARS-CoV-2 virus up to 1,000 times better than previously developed nanobodies. The new nanobodies are also...
Vaccines can’t provide 100% protection, so it’s not a failure or surprise when some vaccinated people get sick with COVID-19. The good news is their cases...
When three companies emerged in the winter of 2020 promising that a fancy new technology called mRNA could pull the world out of a deadly pandemic,...
Two-Thirds Of Indians Have Been Exposed To COVID-19 The Indian Council of Medical Research (ICMR) has released the results of its fourth seroprevalence study which was conducted across...
Early-stage clinical data with CanSino Biologics’ inhaled COVID-19 vaccine show that it was able to stimulate neutralising antibodies The post First published data backs CanSino’s inhaled...
Boehringer Ingelheim’s latecomer antibody therapy for COVID-19 has been side-lined, as the company focuses its attention on its The post Boehringer takes alteplase to phase 3...
We’ve all got used to hailing healthcare staff as heroes over the past year. Of course they deserve The post COVID-19: We don’t need another hero...
Seattle-based biotech company Lumen Bioscience, which manufactures proteins in algae, will expand its manufacturing operations to a former bakery in the city’s Wallingford neighborhood, the company...
A mixed vaccination of first AstraZeneca and then a Pfizer Covid-19 shot boosted neutralizing antibody levels by six times compared with two AstraZeneca doses, a study...
In PerkinElmer's largest purchase ever, the Massachusetts-based company is dropping a massive $5.25 billion in cash and stock to buy the biomedical research tool company BioLegend.
Antibodies triggered by Sinovac Biotech's Covid-19 vaccine decline below a key threshold from around six months after a second dose for most recipients, although a third...
A longer gap between doses of Pfizer's Covid-19 vaccine leads to higher overall antibody levels than a shorter gap, a British study found on July 23,...
Intranasal vaccination is needle-free and elicits immunity at the site of infection, the respiratory tract Credit: UAB BIRMINGHAM, Ala. – There are many reasons that an...
Simultaneously high levels of virus and vaccination will give further evidence of just how protective COVID-19 vaccines are.
In just over a year, Celltrion Healthcare says it has identified and delivered a potential treatment for COVID-19. The post COVID-19: Celltrion’s therapeutic option appeared first...